Prediction of cardiovascular disease risk using biomarkers in blood

Area of Science:

• Biochemistry
• Cardiology
• Clinical Diagnostics

Background:

• Cardiovascular disease (CVD) poses a significant health burden.
• Accurate prediction of CVD risk is crucial for timely intervention.
• Biomarkers in blood offer a potential avenue for CVD risk assessment.

Purpose of the Study:

• To evaluate the predictive value of specific blood biomarkers for cardiovascular disease (CVD).
• To assess the diagnostic accuracy of C-reactive protein (CRP), Troponin I, LDL, HDL, and IL-6 in differentiating CVD and non-CVD groups.
• To determine the efficacy of a combined biomarker model for CVD risk stratification.

Main Methods:

• A cohort of 300 participants was analyzed.
• Levels of C-reactive protein (CRP), Troponin I, LDL, HDL, and IL-6 were measured.
• Statistical analysis was performed to compare biomarker levels between CVD and non-CVD groups and assess predictive accuracy (AUC, sensitivity, specificity).

Main Results:

• Significant differences in biomarker levels were observed between CVD and non-CVD groups.
• C-reactive protein (CRP) and Troponin I exhibited the highest predictive accuracy, with AUCs of 0.89 and 0.85, respectively.
• A combined model using CRP, Troponin I, and LDL achieved 88% sensitivity and 84% specificity.

Conclusions:

• Blood biomarkers including CRP, Troponin I, and LDL can effectively predict cardiovascular disease risk.
• These biomarkers demonstrate potential for early CVD detection and risk stratification in clinical settings.
• Further validation of these biomarkers may enhance clinical decision-making for cardiovascular health.